Internal Medicine, Infectious Disease · Springfield, IL
NPI
1124401070
Since 2015
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
751 N Rutledge St Ste 2100
Springfield, IL, 62702
Phone (217) 545-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
604 services
Medicare patients, 2024
275
Average age 69
Drug cost, 2024
$562K
519 prescriptions
Company payments, 2024
$177
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zainab Alnafoosi was code 99233 (hospital e&m - subsequent), 243 times for 155 patients. In total Zainab Alnafoosi billed 604 services in 19 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 243 | 155 | $90.60 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 154 | 96 | $60.63 | $9,337 |
| 99222 Hospital E&M - Initial | Facility | 93 | 89 | $101.05 | $9,398 |
| 99214 Office E&M - Established | Office | 43 | 32 | $85.79 | $3,689 |
| 99213 Office E&M - Established | Office | 21 | 16 | $62.33 | $1,309 |
By year: 2022 $56K for 781 services; 2023 $37K for 442 services; 2024 $50K for 604 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zainab Alnafoosi prescribed most often to Medicare patients was Vancomycin Hcl, with 60 prescriptions and refills. In total Zainab Alnafoosi wrote 519 Medicare prescriptions that cost $562K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 60 | 60 | 18 | $11K |
| Cefepime Hcl Generic | 42 | 42 | Under 11 | $9,981 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 33 | 33 | Under 11 | $130K |
| Ceftriaxone Ceftriaxone Sodium | 32 | 32 | 12 | $1,141 |
| Daptomycin Generic | 26 | 26 | Under 11 | $23K |
| Doxycycline Hyclate Generic | 26 | 40 | Under 11 | $546 |
| Doxycycline Monohydrate Generic | 25 | 46 | Under 11 | $1,790 |
| Meropenem Generic | 24 | 24 | Under 11 | $6,470 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 23 | 27 | 11 | $334 |
| Oxacillin Sodium Generic | 20 | 20 | Under 11 | $12K |
| Tivicay Dolutegravir Sodium | 19 | 19 | Under 11 | $42K |
| Descovy Emtricitabine/Tenofov Alafenam | 18 | 18 | Under 11 | $39K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 | 28 | Under 11 | $222 |
| Itraconazole Generic | 14 | 14 | Under 11 | $6,169 |
| Complera Emtricita/Rilpivirine/Tenof Df | 12 | 12 | Under 11 | $45K |
Brand drugs: 135 claims; generic drugs: 384 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Zainab Alnafoosi $177 ($177 in general payments such as food, travel and fees) from 1 company. The largest payer was Astellas Pharma US Inc with $177.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 2 | $177 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.